Recommendations on Inpatient Treatment of Patients with COVID-19.
暂无分享,去创建一个
[1] D. Follmann,et al. A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia , 2020, The New England journal of medicine.
[2] Arthur S Slutsky,et al. The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline , 2020, Intensive Care Medicine.
[3] R. Malekzadeh,et al. Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results , 2020, medRxiv.
[4] J. Nattermann,et al. First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)” , 2020, Infection.
[5] G. Guyatt,et al. A living WHO guideline on drugs for covid-19 , 2020, BMJ.
[6] Arthur S Slutsky,et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. , 2020, JAMA.
[7] Arthur S Slutsky,et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study , 2020, The Lancet Respiratory Medicine.
[8] M. Hauptmann,et al. Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study , 2020, Clinical Microbiology and Infection.
[9] A. J. Agulló,et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS , 2020, Intensive Care Medicine.
[10] G. Michels,et al. Entscheidungen über die Zuteilung intensivmedizinischer Ressourcen im Kontext der COVID-19-Pandemie , 2020, Medizinische Klinik - Intensivmedizin und Notfallmedizin.
[11] R. Busse,et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study , 2020, The Lancet Respiratory Medicine.
[12] D. MacFadden,et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis , 2020, Clinical Microbiology and Infection.
[13] Sharon J Peacock,et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.
[14] Angelo Carfì,et al. Persistent Symptoms in Patients After Acute COVID-19. , 2020, JAMA.
[15] Jennifer L. Bell,et al. Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.
[16] Chaofei Han,et al. Procalcitonin levels in COVID-19 patients , 2020, International Journal of Antimicrobial Agents.
[17] N. Patel. Pediatric COVID-19: Systematic review of the literature , 2020, American Journal of Otolaryngology.
[18] J. Oldenburg,et al. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis , 2020, Hämostaseologie.
[19] L. Dodd,et al. Remdesivir for the Treatment of Covid-19 — Final Report , 2020, The New England journal of medicine.
[20] P. Horby,et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study , 2020, BMJ.
[21] Axel Haverich,et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.
[22] O. Moerer,et al. COVID-19-associated nephritis: early warning for disease severity and complications? , 2020, The Lancet.
[23] M. Aepfelbacher,et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 , 2020, Annals of Internal Medicine.
[24] D. Brodie,et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, medRxiv.
[25] Giuseppe Citerio,et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) , 2020, Intensive Care Medicine.
[26] T. Cook,et al. Consensus guidelines for managing the airway in patients with COVID‐19 , 2020, Anaesthesia.
[27] T. Welte,et al. [Recommendations for critically ill patients with COVID-19]. , 2020, Medizinische Klinik, Intensivmedizin und Notfallmedizin.
[28] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[29] Wei Wang,et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.
[30] Guillermo J. Lagos-Grisales,et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis , 2020, Travel Medicine and Infectious Disease.
[31] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[32] Sujata,et al. A Prospective Study of Neurologic Disorders in Hospitalized COVID-19 Patients in New York City , 2020 .
[33] I. Hickie,et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study , 2006, BMJ : British Medical Journal.